Drug causes tumour cells to self-destruct

[Guest guest]

http://tomorrowsmedicinetoday.blogspot.com/2007/10/drug-causes-tumour-cells-to-s\

elf.html

 

Drug causes tumour cells to self-destruct

Tuesday, October 2, 2007

 

Drug causes tumour cells to self-destruct :

 

Barcelona: Doctors are hopeful about a new drug to treat skin cancer by

causing tumor cells to self-destruct by overloading them with oxygen.

 

Unlike regular cells, which naturally cannot have their oxidant levels

raised beyond a certain threshold, cancer cells cannot balance the

amount of free radicals inside them.

 

With the new drug STA-4783, doctors may be able to overload the cancer

cells with oxygen-containing chemicals to the point where the cells

cannot cope and simply die off, according to research presented

Wednesday at a meeting of the European Cancer Organization in Barcelona.

“We are taking advantage of the Achilles heel of cancer

cells,†said Dr Anthony Williams, vice president of clinical

research at Synta Pharmaceuticals Corp, based in Lexington,

Massachusetts, which paid for the study. STA-4783, which has no effect

on normal cells, is the first of several such drugs planned for study,

though no other companies have yet to release results from their

research.

 

It could also be used against other cancers, such as pancreatic or

ovarian, as they have been shown to naturally contain higher levels of

oxygen. Because cancerous tumor cells already have high oxygen levels,

they are easier to overload. Doctors said the study focused on skin

cancer, though, as melanoma tumors were particularly deadly. Williams

detailed how the drug doubled the amount of time that advanced melanoma

patients survived without their cancer worsening.

 

The study followed 81 patients with serious skin cancer: 28 received the

standard chemotherapy drug paclitaxel and lived an average of 1.8

months, while 53 got paclitaxel plus the new drug and survived an

average of 3.7 months. Because STA-4783 targets only cancer cells,

Williams said the drug does not come with too many side effects. Less

than 5% of patients suffered serious side effects, which were similar to

those seen in regular chemotherapy treatments, such as a temporary

lowering of white blood cells, back pain and fatigue. AP

source:timesofindia

Labels: Drugcauses, tumourcells

posted by AMIT BHATIA @ 6:47 AM    

[Guest guest]

" The study followed 81 patients with serious skin cancer: 28 received

the standard chemotherapy drug paclitaxel and lived an average of 1.8

months, while 53 got paclitaxel plus the new drug and survived an

average of 3.7 months "

 

All of this over a drug that gives an average of two exta months over

standard chemo, which only itself gives an average of anextra month

or two at best?

 

We who favor natural health have long preached the benefits of

getting extra oxygen in and around cancer cells. It is but one of

many things to do in an effective anti-cancer protocol. NONE of them

are drugs!

 

 

oleander soup , robert-blau wrote:

>

> http://tomorrowsmedicinetoday.blogspot.com/2007/10/drug-causes-

tumour-cells-to-self.html

>  

> Drug causes tumour cells to self-destruct

> Tuesday, October 2, 2007

>

> Drug causes tumour cells to self-destruct :

>

> Barcelona: Doctors are hopeful about a new drug to treat skin

cancer by

> causing tumor cells to self-destruct by overloading them with

oxygen.

>

> Unlike regular cells, which naturally cannot have their oxidant

levels

> raised beyond a certain threshold, cancer cells cannot balance the

> amount of free radicals inside them.

>

> With the new drug STA-4783, doctors may be able to overload the

cancer

> cells with oxygen-containing chemicals to the point where the cells

> cannot cope and simply die off, according to research presented

> Wednesday at a meeting of the European Cancer Organization in

Barcelona.

> “We are taking advantage of the Achilles heel of cancer

> cells,†said Dr Anthony Williams, vice president of clinical

> research at Synta Pharmaceuticals Corp, based in Lexington,

> Massachusetts, which paid for the study. STA-4783, which has no

effect

> on normal cells, is the first of several such drugs planned for

study,

> though no other companies have yet to release results from their

> research.

>

> It could also be used against other cancers, such as pancreatic or

> ovarian, as they have been shown to naturally contain higher levels

of

> oxygen. Because cancerous tumor cells already have high oxygen

levels,

> they are easier to overload. Doctors said the study focused on skin

> cancer, though, as melanoma tumors were particularly deadly.

Williams

> detailed how the drug doubled the amount of time that advanced

melanoma

> patients survived without their cancer worsening.

>

> The study followed 81 patients with serious skin cancer: 28

received the

> standard chemotherapy drug paclitaxel and lived an average of 1.8

> months, while 53 got paclitaxel plus the new drug and survived an

> average of 3.7 months. Because STA-4783 targets only cancer cells,

> Williams said the drug does not come with too many side effects.

Less

> than 5% of patients suffered serious side effects, which were

similar to

> those seen in regular chemotherapy treatments, such as a temporary

> lowering of white blood cells, back pain and fatigue. AP

> source:timesofindia

> Labels: Drugcauses, tumourcells

> posted by AMIT BHATIA @ 6:47 AM    

>